ITEMS IN AFP WITH KEYWORD:
Jun 1, 2019 Issue
Anticoagulation for the Long-term Treatment of VTE in Patients with Cancer [Cochrane for Clinicians]
Low-molecular-weight heparin (LMWH), vitamin K antagonists, and direct oral anticoagulants, when used to prevent recurrent VTE, have a similar impact on all-cause mortality.
Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.
We all need to test wisely and weigh the risks and benefits of diagnostic imaging. Imaging—and testing in general—has real downsides, such as stumbling onto things you wish you had not.
Kidney cancer is one of the 10 most common cancers in the United States. Risk factors include hypertension, tobacco use, obesity, and acquired cystic kidney disease in the setting of end-stage renal disease. More than 50% of patients with renal cell carcinoma are asymptomatic and are diagnosed incidentally during thoracoabdominal imaging. Prompt evaluation of warning signs can improve prognosis, and active surveillance is an option for certain patients.
To support early identification and treatment, the American Cancer Society (ACS) has updated its 2008 guidance on counseling and referring patients at average risk of colorectal cancer (CRC) based on new evidence regarding screening options and the ever-changing risk of CRC.
The primary care physician's role in cancer treatment.
Patients with multiple myeloma may demonstrate presence of the disease through blood testing alone or nonspecific symptoms. Infection, adverse treatment effects, and complications are common and require close monitoring.
Studies show no deaths were prevented and 1 in 5 underwent a prostate biopsy for a false-positive test. Read more.
Jan 15, 2015 Issue
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women [Putting Prevention into Practice]
L.M. is a 37-year-old nonsmoking woman who is not taking any medications and has no significant past medical problems. Three of her female relatives have a history of breast cancer: her mother (diagnosed at 49 years of age, before menopause), her paternal grandmother (diagnosed at 72 years of age), ...
Jan 15, 2015 Issue
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends that primary care clinicians screen women who have family members with breast, ovarian, tubal, or peritoneal cancer with one of several screening tools designed to identify a family history that may be associated with an increased risk of p...